Sugi Predict

Sugi Predict / Compounds / SCHEMBL4367433

SCHEMBL4367433

SCHEMBL4367433

Cc1ccc(S(=O)(=O)N(C(=O)OC(C)(C)C)[C@@H]2CCCC[C@H]2N)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT5B P51692 2/20 0.39
▸ STAT3 P40763 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPSR1 Q6W5P4 4/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ ENPP3 O14638 2/20 0.36
▸ ENPP1 P22413 2/20 0.36
▸ ENPP2 Q13822 2/20 0.36
▸ F2 P00734 1/20 0.36
▸ TAS2R14 Q9NYV8 2/20 0.35
▸ NR1D1 P20393 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ MMP13 P45452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9114934 1.00 STAT5B (0.39) STAT5BSTAT3ALDH1A1MEN1KMT2A
SCHEMBL30689711 0.81 ALDH1A1 (0.36) STAT5BSTAT3ALDH1A1MEN1KMT2A
SCHEMBL28010137 0.76 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ASMN1; SMN2TP53
SCHEMBL810837 0.74 HTR2A (0.51) ALDH1A1MEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL30689733 0.73 NR1D1 (0.35) STAT5BSTAT3MEN1KMT2ATP53
SCHEMBL30865701 0.73 JAK2 (0.35) STAT5BSTAT3MEN1KMT2AL3MBTL1
SCHEMBL2960697 0.72 AGER (0.45) STAT5BALDH1A1MEN1KMT2ATP53
SCHEMBL1864283 0.71 ALDH1A1 (0.51) STAT5BALDH1A1F2NR1D1LMNA
SCHEMBL17507932 0.70 HSD11B1 (0.35) —
SCHEMBL5903172 0.70 HSD11B1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090098047-A1 BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS INOTEK PHARMACEUTICALS (NZ) 2009-04-16 — — US disclosed
EP-0891338-A1 BIOCONJUGATES OF MANGANESE OR IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1999-01-20 — — EP disclosed
WO-1997033877-A1 BIOCONJUGATES OF MANGANESE OR IRON COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1997-09-18 — — WO disclosed
WO-1997006824-A2 BIOCONJUGATES OF MANGANESE COMPLEXES AND THEIR APPLICATION AS CATALYSTS MONSANTO COMPANY (US) 1997-02-27 — — WO disclosed
EP-0756495-A1 DIAGNOSTIC IMAGE ANALYSIS WITH METAL COMPLEXES MONSANTO COMPANY (US) 1997-02-05 — — EP disclosed
WO-1995028968-A1 DIAGNOSTIC IMAGE ANALYSIS WITH METAL COMPLEXES MONSANTO COMPANY (US) 1995-11-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090098047-A1 BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS RXFP3, RXFP1, C3AR1 STAT5B 4236/4885STAT3 3565/4885ALDH1A1 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.